ACTIVE INGREDIENT: Levonorgestrel/Ethinylestradiol
STRENGTH & PACK SIZE & GMS CODES:
100μg/20μg Coated Tablets x 63 ~ 68202
The decision to prescribe Leonore should take into consideration the individual woman’s current risk factors, particularly those for venous thromboembolism (VTE), and how the risk of VTE with Leonore compares with other combined hormonal contraceptives (CHCs).
Download Leonore 100μg/20μg SPC and Patient Information Leaflet here